YANK2 mRNA expression was mainly enhanced in normal kidney and lymphoid tissue and detected in many cancers, such as high expression in adrenocortical cancer and skin cancer (https://www.proteinatlas.org/ENSG00000152953-STK32B/tissue). This evidence concerns the gene STK32B and adrenal cortex carcinoma.